← Leaderboards
Richard Douglas Moore
Johns Hopkins University
$80,558,192
Attributed
$96,614,103
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$96,614,103 · 9
By mechanism
U01$75,878,785 · 2
R01$12,039,204 · 2
P30$6,813,457 · 3
K24$1,494,345 · 1
R21$388,312 · 1
Top collaborators
- Keri Nicole Althoff10 shared
- Kelly A Gebo2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Martin G Pomper$38,517,075
- Richard J Jones$17,555,212
- Gregory D Kirk$60,349,977
- William George Nelson$34,555,726
- Elizabeth Marion Jaffee$29,780,612
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsComorbidityCohortAcquired Immunodeficiency SyndromeClinical ResearchResearch PersonnelPersonsCollaborationsResourcesCaringEpidemiologyViralEpidemicHepatitis CIncidenceTreatment OutcomeAntiretroviral TherapyResponseRisk FactorsMorbidity - Disease RateDrug UsageInfectionKidneyAids/Hiv Problem
Grant awards (73)
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$3,700,000
U01 · FY2025 · AI
Clinical Core$697,894
P30 · FY2025 · AI · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$3,700,000
U01 · FY2024 · AI
Johns Hopkins HIV Clinical Cohort$1,543,732
U01 · FY2024 · DA · contact PI
Clinical Core$785,925
P30 · FY2024 · AI · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$3,700,000
U01 · FY2023 · AI
Johns Hopkins HIV Clinical Cohort$1,470,508
U01 · FY2023 · DA · contact PI
Clinical Core$826,172
P30 · FY2023 · AI · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$3,999,905
U01 · FY2022 · AI
Johns Hopkins HIV Clinical Cohort$1,470,508
U01 · FY2022 · DA · contact PI
Clinical Core$783,784
P30 · FY2022 · AI · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$4,277,114
U01 · FY2021 · AI · contact PI
Johns Hopkins HIV Clinical Cohort$1,470,508
U01 · FY2021 · DA · contact PI
Clinical Core$579,410
P30 · FY2021 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$2,939,133
U01 · FY2020 · AI · contact PI
Johns Hopkins HIV Clinical Cohort$1,473,128
U01 · FY2020 · DA · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$906,511
U01 · FY2020 · AI · contact PI
Clinical Core$581,522
P30 · FY2020 · AI · contact PI
NA-ACCORD COVID-19 Supplment$152,652
U01 · FY2020 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$3,109,247
U01 · FY2019 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,496,559
U01 · FY2019 · DA · contact PI
Clinical Core$538,189
P30 · FY2019 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$3,060,625
U01 · FY2018 · AI · contact PI
Clinical Core$876,663
P30 · FY2018 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$3,042,742
U01 · FY2017 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,496,559
U01 · FY2017 · DA · contact PI
Clinical Core$677,331
P30 · FY2017 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal$2,700,000
U01 · FY2016 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,492,893
U01 · FY2016 · DA · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$1,904,690
U01 · FY2015 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,474,110
U01 · FY2015 · DA · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$2,500,335
U01 · FY2014 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,511,362
U01 · FY2014 · DA · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$1,904,692
U01 · FY2013 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$635,932
R01 · FY2013 · DA · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$2,166,017
U01 · FY2012 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$683,258
R01 · FY2012 · DA · contact PI
Clinical$466,567
P30 · FY2012 · AI · contact PI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)$2,276,122
U01 · FY2011 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$702,056
R01 · FY2011 · DA · contact PI
Alcohol and HIV Treatment and Clinical Progression$351,135
R01 · FY2011 · AA · contact PI
North American AIDS Cohorts Collaboration on Research and Design$1,710,138
U01 · FY2010 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$724,408
R01 · FY2010 · DA · contact PI
Alcohol and HIV Treatment and Clinical Progression$328,779
R01 · FY2010 · AA · contact PI
North American AIDS Cohorts Collaboration on Research and Design$7,312,062
U01 · FY2009 · AI · contact PI
North American AIDS Cohorts Collaboration on Research and Design$1,502,251
U01 · FY2009 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$703,568
R01 · FY2009 · DA · contact PI
Alcohol and HIV Treatment and Clinical Progression$295,200
R01 · FY2009 · AA · contact PI
HIV and Substance Abuse$176,103
K24 · FY2009 · DA · contact PI
North American AIDS Cohorts Collaboration on Research and Design$1,647,789
U01 · FY2008 · AI · contact PI
Alcohol and HIV Treatment and Clinical Progression$295,200
R01 · FY2008 · AA · contact PI
HIV and Substance Abuse$174,696
K24 · FY2008 · DA · contact PI
North American AIDS Cohorts Collaboration on Research and Design$1,460,402
U01 · FY2007 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,047,335
R01 · FY2007 · DA · contact PI
HIV and Substance Abuse$173,332
K24 · FY2007 · DA · contact PI
North American AIDS Cohorts Collaboration on Research and Design$1,306,491
U01 · FY2006 · AI · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,038,079
R01 · FY2006 · DA · contact PI
HIV and Substance Abuse$172,005
K24 · FY2006 · DA · contact PI
HIV Disease Outcomes in Drug Users in Clinical Practice$1,029,864
R01 · FY2005 · DA
Alcohol and HIV Progression in the Hopkins HIV Cohort$194,156
R21 · FY2005 · AA
HIV and Substance Abuse$173,439
K24 · FY2005 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice$985,539
R01 · FY2004 · DA
Alcohol and HIV Progression in the Hopkins HIV Cohort$194,156
R21 · FY2004 · AA
MID CAREER INVESTIGATOR AWARD$124,749
K24 · FY2004 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice$981,603
R01 · FY2003 · DA
MID CAREER INVESTIGATOR AWARD$124,858
K24 · FY2003 · DA
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICE$611,506
R01 · FY2002 · DA
MID CAREER INVESTIGATOR AWARD$124,960
K24 · FY2002 · DA
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICE$807,007
R01 · FY2001 · DA
MID CAREER INVESTIGATOR AWARD$125,056
K24 · FY2001 · DA
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICE$692,353
R01 · FY2000 · DA
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICE$126,382
R01 · FY2000 · DA
MID CAREER INVESTIGATOR AWARD$125,147
K24 · FY2000 · DA